A Systematic Review and Meta-Analysis of Randomized Controlled Trials With Novel Hormonal Therapies for Non-Metastatic Castration-Resistant Prostate Cancer: An Update From Mature Overall Survival Data
IntroductionTo get better insight into the management of non-metastatic castration-resistant prostate cancer (M0 CRPC), in this meta-analysis and review we aimed to present an updated evaluation of the efficacy and safety of novel hormonal therapies (nHT) for M0 CRPC according to final analyses with...
Main Authors: | Martina Maggi, Stefano Salciccia, Francesco Del Giudice, Gian Maria Busetto, Ugo G. Falagario, Giuseppe Carrieri, Matteo Ferro, Angelo Porreca, Giovanni Battista Di Pierro, Vittorio Fasulo, Viviana Frantellizzi, Giuseppe De Vincentis, Ettore De Berardinis, Alessandro Sciarra |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-06-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2021.700258/full |
Similar Items
-
Prostatic Neoplasia in the Intact and Castrated Dog: How Dangerous is Castration?
by: Magdalena Schrank, et al.
Published: (2020-01-01) -
Overall survival prediction in metastatic castration-resistant prostate cancer treated with radium-223
by: Monica Vidal, et al. -
Experimental study of apoptosis in the prostate tissue following castration
by: Y Doustar, et al.
Published: (2008-02-01) -
Prostate radiation in non-metastatic castrate refractory prostate cancer provides an interesting insight into biology of prostate cancer
by: Pascoe Abigail C, et al.
Published: (2012-03-01) -
Drug treatment opportunities of the elderly patients with the metastatic castration-resistant prostate cancer
by: V. A. Solodkiy, et al.
Published: (2017-04-01)